For clinicians · research decision-support, pending external validation. These tools support — they do not replace — multidisciplinary clinical judgment, and are not validated medical devices. No patient data is stored; everything runs in your browser.

Available tools

Pick a tool below. Tools marked Live are ready to use now. This is a working platform name and layout — both are easy to change.

ADAPT-EMLive
Endometrial carcinoma · adjuvant therapy
Molecular-anchored adjuvant therapy decision support (POLE / MMRd / NSMP / p53abn). Ranks strategies by net clinical benefit, derives FIGO 2009 & 2023 stage with discordance flagging, generates an EMR tumor-board note and a plain-language patient summary, with PubMed-linked trial evidence.
Open tool →
OvAR-TxIn development
Ovarian (HGSOC) · therapy prediction
Multi-omic, HR-status-aware therapy and maintenance prediction for high-grade serous ovarian cancer. Being prepared for integration into the platform.
Coming soon
More toolsPlanned
Cervical · vulvar · risk models
Additional gynecologic-oncology calculators can be added as data — each with its source model, validation, and a named clinical reviewer.
Planned

How these tools are built

Transparent. Every recommendation shows the model logic and the underlying trials, with links to the primary literature — so a clinician can independently review the basis.

Private by design. All computation happens locally in your browser. Nothing you enter is stored or transmitted.

Governed. Before any tool is used in care, it carries its source model, validation status, a named clinical reviewer, and a version date. ADAPT-EM is currently a research decision-support prototype pending external validation.

Author

Adrian Kohut, MD